Patents-Review.com
ClassID:

116874 ⎘

C12Y304/21077 - CPC Classification

Classification description:

Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Serine endopeptidases (3.4.21) Semenogelase (3.4.21.77), i.e. prostate specific antigen or PSA or kallikrein 3

Recent Application in this class:
#1
20250101399
2025-03-27

Consensus Prostate Antigens, Nucleic Acid Molecule Encoding The Same And Vaccine And Uses Comprising The Same

 #2
20220016228
2022-01-20

Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

 #3
20200069785
2020-03-05

Compositions and methods comprising KLK3 or FOLH1 antigen

 #4
20190120846
2019-04-25

CELL SURFACE PROSTATE CANCER ANTIGEN FOR DIAGNOSIS

 #5
20190046621
2019-02-14

Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

 #6
20180369352
2018-12-27

Vectors for expression of prostate-associated antigens

 #7
20180325964
2018-11-15

MANUFACTURING DEVICE AND METHOD OF AN IMMUNOTHERAPEUTIC FORMULATION COMPRISING A RECOMBINANT LISTERIA STRAIN

 #8
20180305702
2018-10-25

Listeria-Based Immunogenic Compositions And Methods Of Use Thereof in Cancer Prevention And Treatment

 #9
20180085753
2018-03-29

FLUIDIC SYSTEMS AND METHODS FOR ANALYSES

 #10
20170196957
2017-07-13

RECOMBINANT T CELL RECEPTOR LIGAND COMPOSITIONS AND METHODS FOR TREATMENT OF PROSTATE CANCER

 #11
20170100469
2017-04-13

COMPOSITIONS AND METHODS COMPRISING KLK3 OR FOLH1 ANTIGEN

 #12
20160361403
2016-12-15

Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

 #13
20160349263
2016-12-01

Cell surface prostate cancer antigen for diagnosis

 #14
20160341725
2016-11-24

Analyzing apparatus

 #15
20160305937
2016-10-20

Fluidic systems and methods for analyses

 #16
20160305878
2016-10-20

Fluidic systems and methods for analyses

 #17
20160235829
2016-08-18

Vectors for expression of prostate-associated antigens

 #18
20150335721
2015-11-26

Compositions and methods comprising KLK3 or FOLH1 antigen

 #19
20150284444
2015-10-08

PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT INCLUDING FUSION PROTEIN

 #20
20150150957
2015-06-04

Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

 #21
20150065373
2015-03-05

Urinary biomarker for use in test for prostate cancer

 #22
20140308168
2014-10-16

Structures for controlling light interaction with microfluidic devices

 #23
20120237401
2012-09-20

Structures for controlling light interaction with microfluidic devices

 #24
20100196207
2010-08-05

Structures for controlling light interaction with microfluidic devices

 #25
20070253976
2007-11-01

Compositions and methods comprising KLK3 of FOLH1 antigen

 #26
20060223744
2006-10-05

Prostate specific antigens and uses thereof